Greenville Health System Cancer Institute-Seneca is a clinical research site located in Seneca, South Carolina, United States 29672.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Greenville Health System Cancer Institute-Seneca has participated in 68 clinical trials with 9 currently active.
Therapeutic areas: Plasma Cell Myeloma, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Greenville Health System Cancer Institute-Seneca has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Greenville Health System Cancer Institute-Seneca has 68 clinical trials on record, with 9 currently active. Their work covers Plasma Cell Myeloma, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer.
Yes — Greenville Health System Cancer Institute-Seneca holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.